Autophagy Revives Dying Cancer Cells

Self digestion thwarts self destruction.

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, NATIONAL INSTITUTES OF HEALTHCancer cells in the throes of death, being ripped apart from the inside by apoptosis, can evidently survive and piece themselves back together. A study published last month (March 27) in Cell Reports and presented this week at the American Association for Cancer Research (AACR) meeting in San Diego, California, demonstrates how cancer cells with heightened autophagy can recover from such destruction. The results offer insight on how cancer cells might be able to withstand chemotherapy.

“The implication here is that if you inhibit autophagy you'd make this less likely to happen, i.e. when you kill cancer cells they would stay dead,” Andrew Thorburn, the senior author of the study and the deputy director of the University of Colorado Cancer Center, said in a press release.

Thorburn’s group looked at HeLa cells treated with a drug called TRAIL, which induces apoptosis. They found that augmenting autophagy in these cells leads to inefficiencies in an apoptotic process called mitochondrial outer membrane permeabilization (MOMP). Usually, cells break up within five minutes of MOMP. But when autophagy was increased, MOMP slugged along, leading to slower cell death and an opportunity for cellular revival.

“Autophagy is complex and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo